Flow Wellness focuses on matching treatment plans to each patients goals, medical history, and response to therapy
That's because Medicare, rather than the Part D insurer, is subsidizing the prescription
26 The TECOS trial, a major multicenter clinical study, compared saxagliptin to placebo in 14,671 individuals with Type 2 diabetes and established cardiovascular disease
[Google Scholar] 20.Sharma S., Raymond E., Soda H., Izbicka E., Davidson K., Lawrence R., von Hoff D.D
Symptoms such as chest discomfort, shortness of breath, or reduced exercise capacity should be assessed by a doctor rather than self-treated with supplements
*Correspondence: Hang Lin, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Tissue Engineering and Regenerative Medicine, a section of the journal Frontiers in Bioengineering and Biotechnology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
